Ana Radeljevic
Direttore/Membro del Consiglio presso MERRIMACK PHARMACEUTICALS, INC.
Posizioni attive di Ana Radeljevic
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 06/06/2022 | - |
| Independent Dir/Board Member | 06/06/2022 | - | |
ADRx, Inc.
 ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/09/2021 | - |
Storia della carriera di Ana Radeljevic
Precedenti posizioni note di Ana Radeljevic
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| REVVITY, INC. | Corporate Officer/Principal | 01/01/2014 | 01/01/2016 |
Formazione di Ana Radeljevic
| Syracuse University | Masters Business Admin |
| Old Dominion University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| REVVITY, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
ADRx, Inc.
ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Health Technology |
- Borsa valori
- Insiders
- Ana Radeljevic
- Esperienza
